ASTA Comments to FDA on Sesame Allergens
ASTA issued comments to the Food and Drug Administration (FDA) in December 2018 in response to the FDA's Request for Comment on Sesame as an Allergen in Foods. The comments support labeling sesame as a major allergen, provided that sufficient time is offered to implement new labeling and GMP requirements.
12/31/2018 at 5:15 am
0
Related Resources
ASTA Letter to Senate Leadership Opposing Food Safety Exemptions for Small Businesses
ASTA issued a letter to Tom Harkin, Chairman of the Health, Education, Labor and Pensions Committee, in November 2019 regarding concerns with the Senators Tester and Hagan amendment from the "Food Safety Modernization Act" exempting small entities.
Coalition Comments to FDA Requesting Sesame Labeling Compliance Date Clarification
ASTA signed onto FBIA coalition comments to the Food and Drug Administration (FDA) in April 2022, requesting that the FDA clarify that the compliance date under the Food Allergy Safety, Treatment, Education, and Research Act (FASTER) means that food products containing sesame must be labeled with a sesame allergen statement on or after January 1, 2021 and that products labeled before that do not need to be in compliance with the FASTER Act.
